JANUS INTERNATIONAL GROUP IN (JBI)

US47103N1063 - Common Stock

7.63  +0.15 (+2.01%)

After market: 7.63 0 (0%)

Fundamental Rating

5

Overall JBI gets a fundamental rating of 5 out of 10. We evaluated JBI against 39 industry peers in the Building Products industry. While JBI has a great profitability rating, there are some minor concerns on its financial health. JBI has a valuation in line with the averages, but it does not seem to be growing.



8

1. Profitability

1.1 Basic Checks

JBI had positive earnings in the past year.
In the past year JBI had a positive cash flow from operations.
Each year in the past 5 years JBI has been profitable.
Each year in the past 5 years JBI had a positive operating cash flow.

1.2 Ratios

The Return On Assets of JBI (8.17%) is comparable to the rest of the industry.
The Return On Equity of JBI (20.09%) is better than 64.10% of its industry peers.
JBI has a better Return On Invested Capital (12.81%) than 64.10% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for JBI is in line with the industry average of 13.33%.
The 3 year average ROIC (11.64%) for JBI is below the current ROIC(12.81%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.17%
ROE 20.09%
ROIC 12.81%
ROA(3y)7.48%
ROA(5y)6.7%
ROE(3y)23.71%
ROE(5y)28.31%
ROIC(3y)11.64%
ROIC(5y)10.45%

1.3 Margins

JBI has a Profit Margin of 10.61%. This is in the better half of the industry: JBI outperforms 64.10% of its industry peers.
In the last couple of years the Profit Margin of JBI has grown nicely.
Looking at the Operating Margin, with a value of 20.11%, JBI belongs to the top of the industry, outperforming 82.05% of the companies in the same industry.
JBI's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 42.64%, JBI belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
JBI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 20.11%
PM (TTM) 10.61%
GM 42.64%
OM growth 3Y10.21%
OM growth 5Y18.15%
PM growth 3Y7.14%
PM growth 5Y38.28%
GM growth 3Y4.34%
GM growth 5Y3.84%

5

2. Health

2.1 Basic Checks

JBI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, JBI has about the same amount of shares outstanding.
JBI has a better debt/assets ratio than last year.

2.2 Solvency

JBI has an Altman-Z score of 2.67. This is not the best score and indicates that JBI is in the grey zone with still only limited risk for bankruptcy at the moment.
JBI has a worse Altman-Z score (2.67) than 69.23% of its industry peers.
The Debt to FCF ratio of JBI is 3.91, which is a good value as it means it would take JBI, 3.91 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 3.91, JBI perfoms like the industry average, outperforming 51.28% of the companies in the same industry.
A Debt/Equity ratio of 1.11 is on the high side and indicates that JBI has dependencies on debt financing.
JBI's Debt to Equity ratio of 1.11 is on the low side compared to the rest of the industry. JBI is outperformed by 87.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 3.91
Altman-Z 2.67
ROIC/WACC1.31
WACC9.78%

2.3 Liquidity

JBI has a Current Ratio of 2.80. This indicates that JBI is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.80, JBI is doing good in the industry, outperforming 76.92% of the companies in the same industry.
JBI has a Quick Ratio of 2.39. This indicates that JBI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.39, JBI belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.8
Quick Ratio 2.39

3

3. Growth

3.1 Past

JBI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.30%.
JBI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 59.32% yearly.
The Revenue has decreased by -7.90% in the past year.
The Revenue has been growing by 17.08% on average over the past years. This is quite good.
EPS 1Y (TTM)-16.3%
EPS 3Y31.1%
EPS 5Y59.32%
EPS Q2Q%-59.26%
Revenue 1Y (TTM)-7.9%
Revenue growth 3Y24.77%
Revenue growth 5Y17.08%
Sales Q2Q%-17.85%

3.2 Future

JBI is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -14.83% yearly.
The Revenue is expected to decrease by -5.87% on average over the next years.
EPS Next Y-41.44%
EPS Next 2Y-32.98%
EPS Next 3Y-14.83%
EPS Next 5YN/A
Revenue Next Year-15.54%
Revenue Next 2Y-11.57%
Revenue Next 3Y-5.87%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.91 indicates a reasonable valuation of JBI.
92.31% of the companies in the same industry are more expensive than JBI, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of JBI to the average of the S&P500 Index (27.20), we can say JBI is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 18.07, the valuation of JBI can be described as rather expensive.
JBI's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 23.73. JBI is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 9.91
Fwd PE 18.07

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JBI is valued cheaper than 100.00% of the companies in the same industry.
JBI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. JBI is cheaper than 97.44% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.1
EV/EBITDA 6.44

4.3 Compensation for Growth

The excellent profitability rating of JBI may justify a higher PE ratio.
A cheap valuation may be justified as JBI's earnings are expected to decrease with -14.83% in the coming years.
PEG (NY)N/A
PEG (5Y)0.17
EPS Next 2Y-32.98%
EPS Next 3Y-14.83%

0

5. Dividend

5.1 Amount

JBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

JANUS INTERNATIONAL GROUP IN

NYSE:JBI (12/20/2024, 8:19:45 PM)

After market: 7.63 0 (0%)

7.63

+0.15 (+2.01%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)10-29 2024-10-29/bmo
Earnings (Next)N/A N/A
Inst Owners115.33%
Inst Owner Change-6.51%
Ins Owners3.86%
Ins Owner Change-0.14%
Market Cap1.08B
Analysts75.56
Price Target9.18 (20.31%)
Short Float %9.53%
Short Ratio5.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-34.91%
Min EPS beat(2)-46.96%
Max EPS beat(2)-22.87%
EPS beat(4)1
Avg EPS beat(4)-17.82%
Min EPS beat(4)-46.96%
Max EPS beat(4)7.41%
EPS beat(8)4
Avg EPS beat(8)-3.98%
EPS beat(12)7
Avg EPS beat(12)5.53%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-10.57%
Min Revenue beat(2)-12.91%
Max Revenue beat(2)-8.24%
Revenue beat(4)0
Avg Revenue beat(4)-7.46%
Min Revenue beat(4)-12.91%
Max Revenue beat(4)-0.36%
Revenue beat(8)4
Avg Revenue beat(8)-2.21%
Revenue beat(12)8
Avg Revenue beat(12)2.83%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-30.77%
PT rev (3m)-36.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-92.19%
EPS NY rev (1m)-11.99%
EPS NY rev (3m)-35.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-32.43%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.82%
Valuation
Industry RankSector Rank
PE 9.91
Fwd PE 18.07
P/S 1.08
P/FCF 7.1
P/OCF 6.29
P/B 2.04
P/tB N/A
EV/EBITDA 6.44
EPS(TTM)0.77
EY10.09%
EPS(NY)0.42
Fwd EY5.53%
FCF(TTM)1.07
FCFY14.08%
OCF(TTM)1.21
OCFY15.9%
SpS7.07
BVpS3.73
TBVpS-1.77
PEG (NY)N/A
PEG (5Y)0.17
Profitability
Industry RankSector Rank
ROA 8.17%
ROE 20.09%
ROCE 17.27%
ROIC 12.81%
ROICexc 14.05%
ROICexgc 52.58%
OM 20.11%
PM (TTM) 10.61%
GM 42.64%
FCFM 15.21%
ROA(3y)7.48%
ROA(5y)6.7%
ROE(3y)23.71%
ROE(5y)28.31%
ROIC(3y)11.64%
ROIC(5y)10.45%
ROICexc(3y)12.87%
ROICexc(5y)11.34%
ROICexgc(3y)54.7%
ROICexgc(5y)77.02%
ROCE(3y)15.69%
ROCE(5y)14.09%
ROICexcg growth 3Y-15.13%
ROICexcg growth 5YN/A
ROICexc growth 3Y23.81%
ROICexc growth 5YN/A
OM growth 3Y10.21%
OM growth 5Y18.15%
PM growth 3Y7.14%
PM growth 5Y38.28%
GM growth 3Y4.34%
GM growth 5Y3.84%
F-Score6
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 3.91
Debt/EBITDA 2.41
Cap/Depr 45.56%
Cap/Sales 1.96%
Interest Coverage 3.86
Cash Conversion 70.32%
Profit Quality 143.29%
Current Ratio 2.8
Quick Ratio 2.39
Altman-Z 2.67
F-Score6
WACC9.78%
ROIC/WACC1.31
Cap/Depr(3y)41.41%
Cap/Depr(5y)33.65%
Cap/Sales(3y)1.77%
Cap/Sales(5y)1.6%
Profit Quality(3y)114.59%
Profit Quality(5y)144.62%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.3%
EPS 3Y31.1%
EPS 5Y59.32%
EPS Q2Q%-59.26%
EPS Next Y-41.44%
EPS Next 2Y-32.98%
EPS Next 3Y-14.83%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.9%
Revenue growth 3Y24.77%
Revenue growth 5Y17.08%
Sales Q2Q%-17.85%
Revenue Next Year-15.54%
Revenue Next 2Y-11.57%
Revenue Next 3Y-5.87%
Revenue Next 5YN/A
EBIT growth 1Y-16.6%
EBIT growth 3Y37.51%
EBIT growth 5Y38.34%
EBIT Next Year-18.8%
EBIT Next 3Y-6.2%
EBIT Next 5YN/A
FCF growth 1Y130.4%
FCF growth 3Y27.53%
FCF growth 5Y42.55%
OCF growth 1Y120.21%
OCF growth 3Y28.72%
OCF growth 5Y37.53%